Sun Pharma Chairman Israel Makov to step down
Sun Pharmaceutical Industries Limited, today announced that its Chairman and member of the Board, Mr Israel Makov, will retire from the company upon the completion of his current term post Sun Pharma's Annual General Meeting on August 29, 2022, after having led the organisation for 10 years.
He was appointed a Board member and the Chairman in 2012. Under his leadership, Sun Pharma transformed from a US$ 1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over US$ 5 billion.
For more details, check out the full story on the link below: